Refine by
Medical School Articles & Analysis
126 news found
Methicillin-resistant Staphylococcus aureus (MRSA) is described by the National Institute for Occupational Safety and Health (NIOSH) as a potentially dangerous type of staph bacteria. Staph, which is commonly carried on the skin or in the nose of healthy people, can sometimes cause infections, but most of these skin infections are minor. With MRSA, which is staph that is resistant to an ...
Are you restless during sleep at night? Do you often wake up at night due to bad dreams or have difficulty in falling asleep? Are you anxious before you sleep? There are a variety of issues that can hamper proper and restful sleep at night, apart from snoring. According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good ...
Biolojic Design has assembled an impressive team of advisors including: Eugene Bauer, PhD, Former CMO and founder of Dermira, Former dean of Stanford Medical School Tim Garnett, MD, Former CMO, Eli Lilly John Hastewell, PhD, Former Head of Novartis Institute for Biomedical Research Biologics Center Michael Hayden, MD, PhD, Former CSO of Teva ...
In the subsequent pursuit of his PhD, he came across a unique surgical glue technology, upon which he co-founded Adhesys Medical. This first venture of his was acquired by the Grunenthal Group in 2017. ...
MedTech Innovator is the leading program for medical devices, digital health and diagnostic companies and is the largest accelerator for life science companies globally. ...
$5.5M financing led by Taiho Ventures LLC, with participation of existing investors, including the Series Seed lead, Kizoo Technology Capital GmbH Fresh capital to be employed to get cellvie Series A ready by accelerating the development of the company's technology platform, strengthening the team, and advancing the mitochondria's GMP manufacturing cellvie Inc., a leader in Therapeutic ...
“Advanced or metastatic ER+, HER2- breast cancer pre-treated with endocrine-based therapy remains an area of unmet medical need. The last endocrine therapy approved was about 20 years ago, and effective endocrine options for this patient population are needed,” said Dr. Aditya Bardia, MD, MPH, Director of Breast Cancer Research at Mass General Cancer Center, Associate ...
The company was founded by Robert Langer and Giovanni Traverso, a gastroenterologist and biomedical engineer from the Department of Mechanical Engineering, MIT and Brigham and Women’s Hospital, Harvard Medical School, and Dr. Carl Schoellhammer. Publications on the technology have appeared in Nature, Gastroenterology, and Science Translational Medicine. ...
The research study, conducted at Mount Sinai Icahn School of Medicine, included 53 adult patients undergoing primary ablative surgery of the oral cavity or oropharynx for squamous cell carcinoma (SCC). ...
Using the Aetion Evidence Platform, the Initiative will help identify when and how RWE can support the goals of advancing efficient access to medication and improving patient care. “xCures has implemented real-time access to retrospective and prospective medical data, including the knowledge captured in unstructured notes and images, through a regulatory ...
ByxCures
BOSTON – November 4, 2022 – Elucid, Inc., a medical technology company providing physicians AI-powered imaging analysis software to characterize cardiovascular disease, has announced that the company’s technology will be featured on the program at the 2022 American Heart Association (AHA) Scientific Sessions, November 5-7, 2022 in Chicago. ...
ByElucid
McCully pioneered the approach of mitochondria augmentation and replacement at Harvard Medical School and the team has now set out to bring it about as a new treatment modality in ischemia-reperfusion injury, aging, and beyond since its founding cellvie has successfully expanded its team and operations close to ...
Panel members included Dr Tamas Alexy, The University of Minnesota Medical School, Dr. Jeffrey Testani, Yale University Medical Center, Dr. ...
BillionToOne , Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new addition to UNITY Screen. For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT ...
Jesse Jupiter, who is the Hansjorg Wyss AO Professor of Orthopaedic Surgery at Harvard Medical School and an internationally known hand and upper extremity specialist who practices at the Massachusetts General Hospital. ...
Jake Kurtis, Chair of Pathology and Laboratory Medicine at the Warren Alpert Medical School Brown University; Scientific co-founder. “Falciparum malaria is a leading cause of death in children world-wide and our global malaria treatment strategy relies almost exclusively on artemisinin-based drugs. ...
Elias, the Dean Emeritus of Medicine and Biological Sciences and Professor of Translational Science, Medicine and Molecular Microbiology and Immunology at Brown University’s Warren Alpert Medical School commented, “We believe we have discovered a master pathway that regulates multiple key cancer-inducing moieties, including critical immune checkpoint ...
The theory is the research team of Mainstein and Rox Anderson of the Wellman Optical Medicine Center of the Massachusetts General Hospital affiliated to Harvard Medical School in the United States. Around 2000, the core point of the theory is that it is no longer layered like traditional laser grinding, but It is to make holes on the surface of the skin to ...
The data, which are featured in a poster at the European Society for Medical Oncology (ESMO) Congress 2022, show an early and encouraging signal of efficacy in the trial’s extensively pre-treated population. ...
Amsel Medical Corp. today announced the expansion of its medical advisory team as the company advances the current product commercialization phase to address the demand for minimally invasive, simple and secure occlusion. ...